Asthma and atopic dermatitis are associated with increased risk of clinical Plasmodium falciparum malaria

BMJ Open

Volumn 3, Issue 7, 2013, Pages

  Herrant, Magali ^a,b   Loucoubar, Cheikh ^a,b,c,d   Bassène, Hubert ^e   Gonçalves, Bronner ^b   Boufkhed, Sabah ^b   Diene Sarr, Fatoumata ^b   Fontanet, Arnaud ^f,g   Tall, Adama ^b   Baril, Laurence ^b   Mercereau Puijalon, Odile ^a   Mécheri, Salaheddine ^a,f   Sakuntabhai, Anavaj ^a,h   Paul, Richard ^a  

^a CNRS   (France)

^b INSTITUT PASTEUR DE DAKAR   (Senegal)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DIDEROT   (France)

^e AIX MARSEILLE UNIVERSITÉ   (France)

^f INSTITUT PASTEUR   (France)

^g University of Paris Cité   (France)

^h Mahidol University   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ALLERGIC DISEASE; ANTIBODY TITER; ARTICLE; ASTHMA; ATOPIC DERMATITIS; ATOPY; BLOOD SMEAR; CHILD; COUGHING; DERMATOPHAGOIDES; DIARRHEA; DISEASE ASSOCIATION; FEMALE; HEADACHE; HELMINTHIASIS; HUMAN; INCIDENCE; INFECTION RISK; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; PARASITE IMMUNITY; PRESCHOOL CHILD; PREVALENCE; RHINOCONJUNCTIVITIS; SENEGAL; SICKLE CELL TRAIT; VOMITING;

EID: 84883315948     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002835     Document Type: Article

References (49)

1. WAO. World Allergy Organization, 2010. http://www.worldallergy.org/ index.php
2. Asher MI, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006;368: 733-43. (Pubitemid 44279052)
3. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7: 145-73. (Pubitemid 19138011)
4. Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood 2008;112: 1557-69.
5. Elghazali G, Perlmann H, Rutta AS, et al. Elevated plasma levels of IgE in Plasmodium falciparum-primed individuals reflect an increased ratio of IL-4 to interferon-gamma (IFN-gamma)-producing cells. Clin Exp Immunol 1997;109: 84-9. (Pubitemid 27293888)
6. Perlmann P, Perlmann H, ElGhazali G, et al. IgE and tumor necrosis factor in malaria infection. Immunol Lett 1999;65: 29-33. (Pubitemid 29074496)
7. Tangteerawatana P, Perlmann H, Hayano M, et al. IL4 gene polymorphism and previous malaria experiences manipulate anti-Plasmodium falciparum antibody isotype profiles in complicated and uncomplicated malaria. Malar J 2009;8: 286-95.
8. Cohen S, McGregor IA, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961;192: 733-7.
9. Perlmann H, Helmby H, Hagstedt M, et al. IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: association of high IgE levels with cerebral malaria. Clin Exp Immunol 1994;97: 284-92. (Pubitemid 24263072)
10. Duarte J, Deshpande P, Guiyedi V, et al. Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status. Malar J 2007;6:1.
11. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354: 541-5. (Pubitemid 29381367)
12. Sigurs N, Gustafsson PM, Bjarnason RS, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Resp Crit Care Med 2005;171: 137-41. (Pubitemid 40105412)
13. Shaheen SO, Aaby P, Hall AJ, et al. Measles and atopy Guinea-Bissau. Lancet 1996;347: 1792-96.
14. McIntire JJ, Umetsu SE, Macaubas C, et al. Immunology: hepatitis A virus link to atopic disease. Nature 2003;425:576. (Pubitemid 37280135)
15. Shirakawa T, Enomoto T, Shimazu S, et al. The inverse association between tuberculin responses and atopic disorder. Science 1997;275: 77-9. (Pubitemid 27020311)
16. Gould HJ, Takhar P, Harries HE, et al. The allergic march from Staphylococcus aureus superantigens to immunoglobulin E. Chem Immunol Allergy 2007;93: 106-36. (Pubitemid 46924875)
17. Jang N, Stewart G, Jones G. Polymorphisms within the PHF11 gene at chromosome 13q14 are associated with childhood atopic dermatitis. Genes Immun 2005;6: 262-4. (Pubitemid 40645571)
18. Kurz T, Hoffjan S, Hayes MG, et al. Fine mapping and positional candidate studies on chromosome 5p13 identify multiple asthma susceptibility loci. J Allergy Clin Immunol 2006;118: 396-402. (Pubitemid 44142715)
19. Zhang Y, Leaves NI, Anderson GG, et al. Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma. Nat Genet 2003;34: 181-6. (Pubitemid 36666929)
20. Sakuntabhai A, Ndiaye R, Casademont I, et al. Genetic determination and linkage mapping of Plasmodium falciparum malaria related traits in Senegal. PLoS ONE 2008;3:e2000.
21. Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007;80: 273-90. (Pubitemid 46175676)
22. Haileamlak A, Dagoye D, Williams H, et al. Early life risk factors for atopic dermatitis in Ethiopian children. J Allergy Clin Immunol 2005;115: 370-6. (Pubitemid 40215105)
23. Kohara Y, Tanabe K, Matsuoka K, et al. A major determinant quantitative-trait locus responsible for atopic dermatitis-like skin lesions in NC/Nga mice is located on Chromosome 9. Immunogenetics 2001;53: 15-21. (Pubitemid 32209408)
24. Beghdadi W, Porcherie A, Schneider BS, et al. Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease. J Exp Med 2008;205: 395-408. (Pubitemid 351281605)
25. Srichaikul T, Archararit N, Siriasawakul T, et al. Histamine changes in Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1976;70: 36-8.
26. Bhattacharya U, Roy S, Kar PK, et al. Histamine & kinin system in experimental malaria. Indian J Med Res 1988;88: 558-63.
27. Trape JF, Tall A, Diagne N, et al. Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect Dis 2011;11: 925-32.
28. Abecasis GR, Cherny SS, Cookson WO, et al. Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2001;30: 97-101.
29. Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995;8: 483-91.
30. Yamada E, Vanna AT, Naspitz CK, et al. International Study of Asthma and Allergies in Childhood (ISAAC): validation of the written questionnaire (eczema component) and prevalence of atopic eczema among Brazilian children. J Investig Allergol Clin Immunol 2002;12: 34-41. (Pubitemid 34507064)
31. Nacher M. Malaria vaccine trials in a wormy world. Trends Parasitol 2001;17: 563-5. (Pubitemid 34088106)
32. Yazdanbakhsh M, Kremsner PG, Van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002;296: 490-4.
33. Lawaly R, Konate L, Marrama L, et al. Impact of mosquito bites on asexual parasite density and gametocyte prevalence in asymptomatic chronic Plasmodium falciparum infections and correlation with IgE and IgG titres. Infect Immun 2012;80: 2240-6.
34. Machado A, Loucoubar C, Grange L, et al. Human genetic contribution to the outcome of infection with malaria parasites. In: Okwa O. ed. Malaria parasites, Rijeka: INTECH, 2012: 267-292.
35. Doolan DL, Dobaño C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev 2009;22: 13-36.
36. Marsh K, Snow RW. Host-parasite interaction and morbidity in malaria endemic areas. Philos Trans R Soc London B 1997;352: 1385-94. (Pubitemid 27434104)
37. Perignon JL, Druilhe P. Immune mechanisms underlying the premonition against Plasmodium falciparum malaria. Mem Inst Oswaldo Cruz 1994;89(Suppl. 2): 51-3.
38. Lell B, Borrmann S, Yazdanbakhsh M, et al. Atopy and malaria. Wien Klin Wochenschr 2001;113: 927-9. (Pubitemid 34041682)
39. Westritschnig K, Sibanda E, Thomas W, et al. Analysis of the sensitization profile towards allergens in central Africa. Clin Exp Allergy 2003;33: 22-7. (Pubitemid 36114903)
40. De Jong EC, Vieira PL, Kalinski P, et al. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J Immunol 2002;168: 1704-9. (Pubitemid 34135767)
41. Baird JK. Age-dependent characteristics of protection versus susceptibility to Plasmodium falciparum. Ann Trop Med Parasitol 1998;92: 367-90. (Pubitemid 28312554)
42. Mecheri S. Contribution of allergic inflammatory response to the pathogenesis of malaria disease. Biochim Biophys Acta 2011;1822: 49-56.
43. Sowunmi A, Gbotosho GO, Happi CT, et al. Enhancement of the antimalarial efficacy of amodiaquine by chlorpheniramine in vivo. Mem Inst Oswaldo Cruz 2007;102: 417-19. (Pubitemid 46869340)
44. Chong CR, Chen X, Shi L, et al. A clinical drug library screen identifies astemizole as an antimalarial agent. Nat Chem Biol 2006;2: 415-16. (Pubitemid 44114918)
45. MacDonald SM, Bhisutthibhan J, Shapiro TA, et al. Immune mimicry in malaria: Plasmodium falciparum secretes a functional histamine-releasing factor homolog in vitro and in vivo. Proc Natl Acad Sci USA 2001;98: 10829-32. (Pubitemid 32878705)
46. De Silva PM, Marshall JM. Factors contributing to urban malaria transmission in sub-Saharan Africa: a systematic review. J Trop Med 2012:819563. doi: 10.1155/2012/819563
47. Bob NS, Diop BM, Renaud F, et al. Parasite polymorphism and severe malaria in Dakar (Senegal): a West African urban area. PLoS ONE 2010;5:e9817.
48. Musonda CC, Whitlock GA, Witty MJ, et al. Chloroquine-astemizole hybrids with potent in vitro and in vivo antiplasmodial activity. Bioorg Med Chem Lett 2009;19: 481-4.
49. Egan TJ, Kaschula CH. Strategies to reverse drug resistance in malaria. Curr Opin Infect Dis 2007;20: 598-604. (Pubitemid 350059519)